Day: January 12, 2026

Kandu, Inc. Announces Appointment of Marshal Linder to Board of Directors and Strategic Growth Investment from K2 HealthVentures and Piper Sandler Merchant Bank

LOS ANGELES, Jan. 12, 2026 /PRNewswire/ -- Kandu, Inc., a healthcare technology company pioneering integrated stroke recovery solutions for post-stroke...

AlphaSense to Outline AI Trends Impacting Drug Discovery and R&D Investment in Biotech and Pharmaceutical Industries at Fierce JPM Week Conference

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- AlphaSense, the AI platform redefining market intelligence for the business and financial world,...

BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions

Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune BiologySAN...

CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia

Additional proof of concept data consistent and strengthen data set shared at ASH 2025Management to host meetings at JP Morgan...

CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia

Additional proof of concept data consistent and strengthen data set shared at ASH 2025Management to host meetings at JP Morgan...

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity

Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS) and Neutropenia through wholly...

error: Content is protected !!